Clinical Trials Directory

Trials / Terminated

TerminatedNCT03104959

Use of NAC in Prevention of Hangover Symptoms; Independent Alcohol Consumption Protocol

Use of N-acetyl Cysteine (NAC) in Alleviation or Prevention of Hangover Symptoms; Independent Alcohol Consumption Protocol

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
St. Luke's Hospital and Health Network, Pennsylvania · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Accepted

Summary

This is a double-blinded study involving healthy non-alcoholic (self-reported) volunteers over the age of 21. Consent is obtained prior to participation in the study while the participant is sober. Volunteers are recruited from residency programs, hospital employees, emergency medical personnel, and friends of the study investigators. If the volunteers choose to drink, they can participate in the study the night of ingestion of alcohol. There is no amount we ask them to drink, and we allow them to withdraw from the study at any time. We never force them to drink alcohol, or even encourage it. The participation is completely voluntary, if they would like to participate and if they choose to drink alcohol, we ask them to participate in the placebo controlled study in the safety of their own home. Then materials for the study are given out prior to their participation. An envelope is given with the questionnaire, and a small packet containing 3 pills of either NAC or placebo, and a small smear of Vicks vapor rub concealed in a small packet. At the end of their alcohol ingestion, the volunteer is asked to estimate the number roof drinks consumed and take 1 capsule per 3 drinks consumed of either 600 mg N-Acetyl-L-Cysteine or placebo capsules. In the morning, each participant fills out a Hangover Symptom Score questionnaire . A random number generator is used to determine placebo or NAC first, then the participant is given the other treatment at their subsequent encounter. Then study is being conducted over a series of many months, and data can be analyzed by the hangover symptoms scale data when using NAC compared to placebo. The data will be analyzed using the numerical values of each category for hangover classification and compare the placebo data to the control data.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTN-acetyl cysteine
OTHERplacebo

Timeline

Start date
2016-01-01
Primary completion
2018-06-06
Completion
2018-06-06
First posted
2017-04-07
Last updated
2018-06-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03104959. Inclusion in this directory is not an endorsement.